                </a></li></ul></div><p><strong>Figure 3.  <span>The selective erbB2 antagonist AG825 dampens the NRG1α-induced MRVA.</span></strong></p><a id="article1.body1.sec2.sec6.fig1.caption1.p1" name="article1.body1.sec2.sec6.fig1.caption1.p1"></a><p>Administration of AG825 in DMSO vehicle (n = 5) caused a robust, dose-dependent decrease in the MRVA induced by NRG1α. Compared with the vehicle control, ** represents p&lt;0.01 and **** represents p&lt;0.0001. Compared with the low dose, + represents p&lt;0.05 and +++ represents p&lt;0.001.</p>
<span>THISISTHEEND
